JIMMIE BLAN: Open Payments
NPI 1093048332 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 21 payments from 9 companies in 2025. Trend: 2023 $727 · 2024 $425 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $100 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Exact Sciences Corporation | 2 | $35 |
| Insulet Corporation | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
Products named: Kerendia, Ozempic, GVOKE HYPOPEN, FARXIGA, Rybelsus, Cologuard Collection Kit, Omnipod, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across AL — which companies pay providers there.
